Richard Miech

Richard Miech

Auto-generated profile, based on publicly available information

Richard Miech

Institute for Social Research, University of Michigan, Ann Arbor

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Epidemiologic Reviews
Verified
Journal Article
Open access
PDF file
CMCarles Muntaner
Carles Muntaner
WEWilliam W. Eaton
William W. Eaton
RMRichard Miech
Richard Miech
POPatricia O’campo
Patricia O’campo
Psychiatric epidemiologists were among the first to use the term “social epidemiology” (1), and the role of the social environment in the etiology and course of major mental disorders continues to be investigated (2–5). A number of reviews published in the late 1990s documented the associations between socioeconomic position (SEP) and specific mental disorders (6–9); in 2003, a comprehensive meta-analysis of the research on SEP and depression (10) concluded that both prevalence and incidence studies show that persons of low SEP (i.e., low educational and low income levels) are at a higher risk of depression.

1 November 2015 in Pediatrics
Verified
Journal Article
Open access
PDF file
RMRichard Miech
Richard Miech
LJLloyd Johnston
Lloyd Johnston
POPatrick M. O’malley
Patrick M. O’malley
KKKatherine M. Keyes
Katherine M. Keyes
KHKennon Heard
Kennon Heard
BACKGROUND AND OBJECTIVE: Legitimate opioid use is associated with an increased risk of long-term opioid use and possibly misuse in adults. The objective of this study was to estimate the risk of future opioid misuse among adolescents who have not yet graduated from high school. METHODS: Prospective, panel data come from the Monitoring the Future study. The analysis uses a nationally representative sample of 6220 individuals surveyed in school in 12th grade and then followed up through age 23. Analyses are stratified by predicted future opioid misuse as measured in 12th grade on the basis of known risk factors. The main outcome is nonmedical use of a prescription opioid at ages 19 to 23. Predictors include use of a legitimate prescription by 12th grade, as well as baseline history of drug use and baseline attitudes toward illegal drug use. RESULTS: Legitimate opioid use before high school graduation is independently associated with a 33% increase in the risk of future opioid misuse after high school. This association is concentrated among individuals who have little to no history of drug use and, as well, strong disapproval of illegal drug use at baseline. CONCLUSIONS: Use of prescribed opioids before the 12th grade is independently associated with future opioid misuse among patients with little drug experience and who disapprove of illegal drug use. Clinic-based education and prevention efforts have substantial potential to reduce future opioid misuse among these individuals, who begin opioid use with strong attitudes against illegal drug use.

1 January 1999 in American Journal of Sociology
Verified
Journal Article
Closed access
RMRichard A. Miech
Richard A. Miech
ACAvshalom Caspi
Avshalom Caspi
TMTerrie E. Moffitt
Terrie E. Moffitt
BWBradley R. Entner Wright
Bradley R. Entner Wright
PSPhil A. Silva
Phil A. Silva

1 June 2000 in Journal of Health and Social Behavior
Verified
Journal Article
Closed access
RMRichard Allen Miech
Richard Allen Miech
MSMichael J. Shanahan
Michael J. Shanahan

18 September 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RMRichard Miech
Richard Miech
LJLloyd Johnston
Lloyd Johnston
POPatrick M. O’mAlley
Patrick M. O’mAlley
JBJerald G. Bachman
Jerald G. Bachman
MPMegan E. Patrick
Megan E. Patrick
The rapid increase in adolescents’ use of electronic cigarettes (known as vaping) during the past decade has aroused public health concern,1 recently heightened by potential links between vaping and acute lung injury.2 Adolescents who vape use a device such as an e-cigarette to inhale a heated aerosol that typically contains nicotine. We assessed whether adolescents’ vaping of nicotine continued to increase from 2018 to 2019, after the previous year’s record increase, the largest for any substance tracked by Monitoring the Future over the past 44 years.1

22 January 2002 in Neurology
Verified
Journal Article
Closed access
PDF file
RMR. A. Miech
R. A. Miech
JBJ. C.S. Breitner
J. C.S. Breitner
PZP. P. Zandi
P. P. Zandi
AKA. S. Khachaturian
A. S. Khachaturian
JAJ. C. Anthony
J. C. Anthony
LML. Mayer
L. Mayer
Objectives: To characterize the incidence of AD among the elderly population of Cache County, UT, noted for its longevity and high response rates; to explore sex differences; and to examine whether AD incidence plateaus or declines in extreme old age. Methods: Using a multistage screening process in 1998 and 1999, and reexamining 122 individuals who had been identified 3 years earlier as cognitively compromised but not demented, the authors found 185 individuals with incident dementia (123 with AD) among 3,308 participants who contributed 10,541 person-years of observation. Adjusting for nonresponse and screening sensitivity, the authors estimated the incidence of dementia and of AD for men and women in 3-year age intervals. Multivariate discrete time survival analysis was used to examine influences of age, sex, education, and genotype at APOE, as well as interactions of these factors. Results: The incidence of both dementia and AD increased almost exponentially until ages 85 to 90, but appeared to decline after age 93 for men and 97 for women. A statistical interaction between age and the presence of two APOE-ε4 alleles indicated acceleration in onset of AD with this genotype; the interaction of age and one ε4 suggested more modest acceleration. A statistical interaction of sex and age indicated greater incidence of AD in women than in men after age 85. Conclusions: The incidence of AD in the Cache County population increased with advancing age, but then peaked and declined among the extremely old. The presence of APOE-ε4 alleles accelerated onset of AD, but did not appreciably alter lifetime incidence apparent over a span of 100 years.